Aim: To compare the performance of three different screening methods (National Institute for Health and Clinical Excellence (NICE) guidelines, American College of Obstetricians and Gynecologists (ACOG) recommendations and Fetal Medicine Foundation (FMF) algorithm) for second trimester prediction of preeclampsia.

Methods: This was a prospective non-intervention study in singleton pregnancies, including women attending for second trimester morphologic ultrasound at 19-22 weeks. Maternal characteristics, medical history, mean arterial pressure and mean uterine artery Doppler pulsatility index were recorded and used for risk assessment. Outcomes measured were preeclampsia with delivery before 34, before 37 and after 37 weeks gestation. Detection rates, false positive rates and positive likelihood ratios were calculated, and receiver operating characteristic curves were produced.

Results: We screened 543 women during the study. The incidence of preeclampsia before 34, before 37 and after 37 weeks was 0.5, 1.4 and 3.4%, respectively. Detection rates for prediction of preterm preeclampsia were 75% (95% CI 34.9-96.8), 87% (95% CI 47.3-99.6), 100% (95% CI 63.0-100) and 100% (95% CI 63.0-100) for NICE guidelines, ACOG recommendations, FMF algorithm with a 1:100 cut-off and FMF algorithm at 1:60 cut-off, respectively. False positive rates were, 22, 67, 19 and 12% for NICE guidelines, ACOG recommendations, FMF algorithm with a 1:100 cut-off and FMF algorithm at 1:60 cut-off, respectively.

Conclusion: Second trimester combined screening for preterm preeclampsia by maternal history, mean arterial pressure and mean uterine artery Doppler pulsatility index (FMF algorithm) was superior to screening by maternal factors alone (NICE guidelines and ACOG recommendations).

Download full-text PDF

Source
http://dx.doi.org/10.1111/ajo.12689DOI Listing

Publication Analysis

Top Keywords

fmf algorithm
24
second trimester
16
nice guidelines
16
acog recommendations
16
preterm preeclampsia
12
guidelines acog
12
trimester prediction
8
prediction preterm
8
three screening
8
history arterial
8

Similar Publications

Background: Colchicine is widely used for gout and familial Mediterranean fever (FMF) and has cardiovascular benefits. However, it is linked to various adverse drug reactions (ADRs). This study aimed to analyze colchicine-related ADRs using FAERS data for safer clinical use.

View Article and Find Full Text PDF

[Screening and prevention of preeclampsia using the Fetal Medicine Foundation algorithm].

Gynecol Obstet Fertil Senol

October 2024

Service de gynécologie obstétrique, CHU Toulouse, Toulouse, France; Centre d'Epidémiologie et de Recherche en Santé des Populations (CERPOP), UMR1295, Université Paul Sabatier University, Toulouse, France.

Article Synopsis
  • The study aimed to determine whether a more restrictive threshold for aspirin prophylaxis (risk >1/70) would effectively identify high-risk nulliparous women for pre-eclampsia compared to the usual threshold (risk >1/100).
  • Conducted at the University Hospital of Toulouse, the study observed two cohorts: one before the screening (2014-2016) and one after implementing the FMF screening and aspirin treatment (2017-2018).
  • Results showed no significant difference in pre-eclampsia rates (1.7% vs. 1.3%) between the two groups, indicating that using the more restrictive threshold did not lead to a decrease in pre-eclampsia with premature delivery
View Article and Find Full Text PDF

Background: Artificial intelligence (AI) has become a popular tool for clinical and research use in the medical field. The aim of this study was to evaluate the accuracy and reliability of a generative AI tool on pediatric familial Mediterranean fever (FMF).

Methods: Fifteen questions repeated thrice on pediatric FMF were prompted to the popular generative AI tool Microsoft Copilot with Chat-GPT 4.

View Article and Find Full Text PDF
Article Synopsis
  • Inflammatory Bowel Diseases (IBD) like Crohn's disease and ulcerative colitis have a higher prevalence of Familial Mediterranean Fever (FMF) compared to non-IBD individuals, with an odds ratio of 2.68.
  • The study analyzed data from a large cohort in Israel, showing that FMF is more common in patients with Crohn's disease than in those with ulcerative colitis, and often the FMF diagnosis comes before IBD.
  • FMF may lead to increased disease severity in patients with ulcerative colitis, while the disease outcomes are similar for Crohn's disease patients with or without FMF.
View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to compare pregnancy rates for preeclampsia in high-risk groups using different algorithms for aspirin prophylaxis screening.
  • Conducted on 1,726 pregnant women between 11 to 13 weeks of gestation, it gathered data on maternal characteristics, medical history, and various health measurements while following guidelines from the Fetal Medicine Foundation (FMF) and NICE.
  • Results showed that the highest identified risk factor was a history of preeclampsia, with varying high-risk rates depending on the screening algorithm used, ranging from 9.9% to 11.8%.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!